2021
DOI: 10.21203/rs.3.rs-584748/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Temporal and spatial topography of cell proliferation in cancer

Abstract: Proliferation is a fundamental trait of cancer cells but is poorly characterized in tumors by classical histologic methods. We use multiplexed tissue imaging to quantify the abundance of multiple cell cycle regulating proteins at single-cell level and develop robust multivariate proliferation metrics. Across cancers, the proliferative architecture is organized at two distinct spatial scales: large domains, and local niches enriched for specific immune lineages. A subset of tumor cells express cell cycle regula… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
12
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5
2

Relationship

4
3

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 13 publications
3
12
0
Order By: Relevance
“…These states are not distinguished by any single marker in our antibody panel, but rather are by high dimensional features. This complexity in cell cycle arrest states is consistent with recent evidence from human tumors 37 and reveals how CyCIF can be used to discriminate drug-induced cell states that appear similar by lower-plex assays. It seems likely that such data, when collected at scale, will assist in identifying drug mechanism of action and response biomarkers.…”
Section: Customizing Dye Drop Assays For Different Endpointssupporting
confidence: 86%
See 1 more Smart Citation
“…These states are not distinguished by any single marker in our antibody panel, but rather are by high dimensional features. This complexity in cell cycle arrest states is consistent with recent evidence from human tumors 37 and reveals how CyCIF can be used to discriminate drug-induced cell states that appear similar by lower-plex assays. It seems likely that such data, when collected at scale, will assist in identifying drug mechanism of action and response biomarkers.…”
Section: Customizing Dye Drop Assays For Different Endpointssupporting
confidence: 86%
“…However, these anticipated relationships masked dramatic variation in basal cell cycle state: under conditions of normal growth, G1 fraction varied from 15% to 86%, G2 fraction from 6% to 40%, and S phase fraction from 4% to 63% with no obvious association with subtype. The distribution of cell cycle states in actual tumors has also been shown to vary within and across cancers 37 and clearly warrants additional study.…”
Section: Pre-treatment Cell Cycle Distributions and Drug-induced Cell...mentioning
confidence: 99%
“…Recent advances in single-cell and multiplexed spatial analysis of tissues are driving large scale inter-institutional and international efforts to systematically characterize the spatial organization of human tumor and immune cells during cancer development and in response to therapy (Rajewsky et al, 2020; Rozenblatt-Rosen et al, 2020). Recurrent spatial features of human cancers are being identified, for example i) active immune surveillance of proliferating tumor cells by cytotoxic T cells (Gaglia et al, 2022; Launonen et al, 2022), ii) chemokine-organized tumor-immune architecture (Nirmal et al, 2022; Pelka et al, 2021), and iii) and cell-cell interactions involved in generating extracellular metabolites such as adenosine, an immunosuppressive purine metabolite of ATP hydrolysis by the CD39 and CD73 ectoenzymes (Coy et al, 2022). These early insights into the tissue cellular neighborhoods and cellular architectures of human cancer tissues have revealed a pressing need for experimental and analytical approaches to investigate the mechanistic underpinnings of the anti-cancer immune response.…”
Section: Discussionmentioning
confidence: 99%
“…FFPE sections were prepared and stained with a 24-plex antibody panel according to the previously described t-CyCIF protocols (Burger et al, 2021; Gaglia et al, 2022; Lin et al, 2018) (see Table S1 ). This CyCIF panel has been validated across many different sample types in accordance with standards defined by our group (Du et al, 2019).…”
Section: Star Methodsmentioning
confidence: 99%
“…Cyclic immunofluorescence (CyCIF) 9 is one such method, enabling quantification of up to 60 antigens at single-cell resolution and generation of maps of functional neighborhoods. Integrating data from scRNA-seq and multiplexed tissue imaging has begun to reveal substantial spatial and molecular variation within human tumors [13][14][15] , and populationlevel regulation of tumor-immune interactions 16 . Such studies promise to reveal novel vulnerabilities in difficult to treat cancers.…”
mentioning
confidence: 99%